Serum Institute Of India Develops First Indigenous Pneumonia Vaccine

The Serum Institute of India has successfully developed the country's first indigenous vaccine against pneumonia. The domestic vaccine will reduce the dependency on earlier two vaccines by Pfizer and GlaxoSmithKline, both foreign drug-makers. After securing approval by the Indian drug regulator in July 2020, the SII has conducted the vaccine's trials in India and the Gambia of Africa. Reportedly, the vaccine will be available in the Indian market by next week.